Correlation Between Apeiron Capital and BioPlus Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apeiron Capital and BioPlus Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apeiron Capital and BioPlus Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apeiron Capital Investment and BioPlus Acquisition Corp, you can compare the effects of market volatilities on Apeiron Capital and BioPlus Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apeiron Capital with a short position of BioPlus Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apeiron Capital and BioPlus Acquisition.

Diversification Opportunities for Apeiron Capital and BioPlus Acquisition

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Apeiron and BioPlus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apeiron Capital Investment and BioPlus Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioPlus Acquisition Corp and Apeiron Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apeiron Capital Investment are associated (or correlated) with BioPlus Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioPlus Acquisition Corp has no effect on the direction of Apeiron Capital i.e., Apeiron Capital and BioPlus Acquisition go up and down completely randomly.

Pair Corralation between Apeiron Capital and BioPlus Acquisition

If you would invest  9.32  in BioPlus Acquisition Corp on August 30, 2024 and sell it today you would earn a total of  4.68  from holding BioPlus Acquisition Corp or generate 50.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Apeiron Capital Investment  vs.  BioPlus Acquisition Corp

 Performance 
       Timeline  
Apeiron Capital Inve 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apeiron Capital Investment has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental indicators, Apeiron Capital is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
BioPlus Acquisition Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioPlus Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BioPlus Acquisition is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Apeiron Capital and BioPlus Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apeiron Capital and BioPlus Acquisition

The main advantage of trading using opposite Apeiron Capital and BioPlus Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apeiron Capital position performs unexpectedly, BioPlus Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioPlus Acquisition will offset losses from the drop in BioPlus Acquisition's long position.
The idea behind Apeiron Capital Investment and BioPlus Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities